tirzepatide news 2025 Eli Lilly H1 2025: Drives 41% Revenue Surge as 4 Clinical Programs Get the Axe BIG NEWS for Zepbound patients!

Tirzepatide for Weight Loss Maintenance Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial, Lancet (2026) [PubMed abstract] BIBLIOGRAPHY 1 - Zepbound PI 2 - PMID 34170647 - Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes, NEJM (2021) 3 - PMID 35133415 - Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial, JAMA (2022) 4 - North Carolina Pharmacy Practice Act

Tissue Repair and Regeneration: BPC-157 has demonstrated remarkable abilities to promote tissue healing and regeneration, making it an invaluable tool in the treatment of musculoskeletal injuries

Unlike weight loss medicine, weight loss devices, bariatric surgery, and liposuction, which may have significant risks or side effects, traditional weight loss methods, such as naturally derived peptides offer a safer, more accessible alternative

It also supports muscle health and long-term metabolic function

Specific food habits, or not drinking enough water, might worsen these burps

Meal timing: Eating 3 balanced meals a day helps to stabilise blood sugar and maximise the medications effects